Initial US respiratory data indicates Fisher & Paykel Healthcare (FPH) is likely to reach the top end of its guidance of between $1.9 billion and $2b in revenue for the 2025 financial year, says Forsyth Barr.
The listed respiratory healthcare company gave guidance of net profit after tax in the
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
